$726 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 29 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 32.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $202,174,000 | +39.3% | 2,082,555 | -1.9% | 27.86% | +28.2% |
| QDEL | Sell | QUIDEL CORP | $107,250,000 | -23.1% | 837,109 | -23.2% | 14.78% | -29.2% |
| OPK | Sell | OPKO HEALTH INC | $51,917,000 | -5.6% | 12,819,073 | -0.0% | 7.16% | -13.1% |
| AGEN | Sell | AGENUS INC | $50,363,000 | +97.5% | 9,173,582 | -2.1% | 6.94% | +81.8% |
| AWH | ASPIRA WOMENS HEALTH INC | $48,597,000 | -16.7% | 8,647,094 | 0.0% | 6.70% | -23.4% | |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $48,054,000 | -0.3% | 1,374,159 | -5.0% | 6.62% | -8.2% |
| VIR | Buy | VIR BIOTECHNOLOGY INC | $33,355,000 | +44.5% | 705,486 | +56.7% | 4.60% | +32.9% |
| AXDX | ACCELERATE DIAGNOSTICS INC | $30,436,000 | -3.1% | 3,776,121 | 0.0% | 4.20% | -10.8% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $30,367,000 | +26.1% | 1,920,733 | -18.9% | 4.18% | +16.1% |
| Sell | DERMTECH INC | $27,265,000 | -24.8% | 655,877 | -8.1% | 3.76% | -30.8% | |
| CDAK | Buy | CODIAK BIOSCIENCES INC | $12,576,000 | +52.9% | 678,700 | +24.4% | 1.73% | +40.7% |
| FORA | Buy | FORIAN INC | $10,915,000 | +594.8% | 868,342 | +458.6% | 1.50% | +540.0% |
| XBI | New | SPDR SER TRs&p biotech | $10,317,000 | – | 76,200 | +100.0% | 1.42% | – |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $10,162,000 | -11.7% | 300,642 | -21.0% | 1.40% | -18.7% |
| ATRS | ANTARES PHARMA INC | $8,284,000 | +6.1% | 1,900,000 | 0.0% | 1.14% | -2.3% | |
| CFRX | Buy | CONTRAFECT CORP | $7,431,000 | -0.3% | 1,688,902 | +8.8% | 1.02% | -8.2% |
| CAPR | Sell | CAPRICOR THERAPEUTICS INC | $5,983,000 | -36.1% | 1,166,249 | -41.7% | 0.82% | -41.1% |
| XBI | New | SPDR SER TRput | $3,898,000 | – | 825,000 | +100.0% | 0.54% | – |
| IMMP | New | IMMUTEP LTDsponsored ads | $3,870,000 | – | 1,000,000 | +100.0% | 0.53% | – |
| MOTS | Sell | MOTUS GI HLDGS INC | $3,845,000 | -15.2% | 3,697,551 | -1.3% | 0.53% | -21.9% |
| SEM | Sell | SELECT MED HLDGS CORP | $3,744,000 | -51.2% | 88,589 | -60.6% | 0.52% | -55.1% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $3,729,000 | -71.2% | 851,335 | -59.2% | 0.51% | -73.5% |
| BDSX | BIODESIX INC | $3,111,000 | -35.0% | 235,511 | 0.0% | 0.43% | -40.1% | |
| SLNO | SOLENO THERAPEUTICS INC | $2,430,000 | -9.5% | 2,132,000 | 0.0% | 0.34% | -16.7% | |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO Lput | $1,820,000 | +10605.9% | 248,200 | +638.7% | 0.25% | +8266.7% |
| VIR | Buy | VIR BIOTECHNOLOGY INCput | $1,313,000 | +494.1% | 196,700 | +935.3% | 0.18% | +448.5% |
| VTNR | New | VERTEX ENERGY INC | $1,191,000 | – | 90,000 | +100.0% | 0.16% | – |
| BIIB | BIOGEN INC | $835,000 | +23.7% | 2,412 | 0.0% | 0.12% | +13.9% | |
| OPK | New | OPKO HEALTH INCput | $334,000 | – | 667,800 | +100.0% | 0.05% | – |
| Exit | DERMTECH INCput | $0 | – | -46,900 | -100.0% | -0.05% | – | |
| QDEL | Exit | QUIDEL CORPput | $0 | – | -50,000 | -100.0% | -0.05% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF INput | $0 | – | -100,000 | -100.0% | -0.08% | – |
| SEM | Exit | SELECT MED HLDGS CORPput | $0 | – | -100,000 | -100.0% | -0.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.